Literature DB >> 21062344

Review: molecular genetics and pathology of hereditary small vessel diseases of the brain.

Y Yamamoto1, L Craggs, M Baumann, H Kalimo, R N Kalaria.   

Abstract

Advances in molecular genetics have enabled identification of several monogenic conditions involving small vessels predisposing to ischaemic and haemorrhagic strokes and diffuse white matter disease. With emphasis on cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), we review the molecular pathogenesis of recently characterized disorders including cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), retinal vasculopathy with cerebral leukodystrophy (RVCL) and the Collagen type IV, alpha 1 (COL4A1)-related disorders. CADASIL remains the most common hereditary small vessel disease (SVD) caused by >190 different mutations in the NOTCH3 gene, which encodes a cell-signalling receptor. Mutant NOTCH3 instigates degeneration of vascular smooth muscle cells in small arteries and arterioles leading to recurrent lacunar infarcts. Mutations in the serine protease HTRA1 gene are associated with CARASIL. Aberrant HTRA1 activity results in increased transforming growth factor-β signalling provoking multiple actions including vascular fibrosis and extracellular matrix synthesis. The RVCL disorders characterized by profound retinopathy are associated with mutations in TREX1, which encodes an abundant 3'-5' DNA-specific exonuclease. TREX1 mutations lead to detrimental gain-of-function or insufficient quantities of enzyme. The COL4A1-related disorders are highly variable comprising four major phenotypes with overlapping systemic and central nervous system features including SVD with cerebral haemorrhages in children and adults. Mutant COL4A1 likely disrupts the extracellular matrix resulting in fragile vessel walls. The hereditary SVDs albeit with variable phenotypes demonstrate how effects of different defective genes converge to produce the characteristic arteriopathy and microvascular disintegration leading to vascular cognitive impairment.
© 2011 The Authors. Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21062344     DOI: 10.1111/j.1365-2990.2010.01147.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  39 in total

Review 1.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 2.  Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Masafumi Ihara; Albertino Damasceno; Adesola Ogunniyi; Catherine Dotchin; Stella-Maria Paddick; Julius Ogeng'o; Richard Walker; Raj N Kalaria
Journal:  Brain Res Bull       Date:  2018-05-25       Impact factor: 4.077

Review 3.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

Review 4.  Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Anne Joutel; Frank M Faraci
Journal:  Stroke       Date:  2014-02-06       Impact factor: 7.914

5.  Assessment of vascular regeneration in the CNS using the mouse retina.

Authors:  Khalil Miloudi; Agnieszka Dejda; François Binet; Eric Lapalme; Agustin Cerani; Przemyslaw Sapieha
Journal:  J Vis Exp       Date:  2014-06-23       Impact factor: 1.355

Review 6.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

Review 7.  Pathophysiology of the neurovascular unit: disease cause or consequence?

Authors:  Danica B Stanimirovic; Alon Friedman
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-07       Impact factor: 6.200

8.  Presymptomatic genetic testing in CADASIL.

Authors:  S Reyes; A Kurtz; D Hervé; E Tournier-Lasserve; H Chabriat
Journal:  J Neurol       Date:  2012-03-15       Impact factor: 4.849

Review 9.  Smooth muscle cell phenotypic switching in stroke.

Authors:  Marine Poittevin; Pierre Lozeron; Rose Hilal; Bernard I Levy; Tatiana Merkulova-Rainon; Nathalie Kubis
Journal:  Transl Stroke Res       Date:  2013-11-22       Impact factor: 6.829

10.  Mutational screening of NOTCH3 gene reveals two novel mutations: complexity of CADASIL diagnosis.

Authors:  Lorena Mosca; Francesca Rivieri; Raffaella Tanel; Aldo Bonfante; Alessandro Burlina; Emanuela Manfredini; Paola Primignani; Giovanni P Gesu; Alessandro Marocchi; Silvana Penco
Journal:  J Mol Neurosci       Date:  2014-05-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.